Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05326750 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 6 entries
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: 3 to 5
  2. 2 versions Re-verified since Jan 17, 2024, no change to tracked fieldsv3-v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 2022 to Nov 21, 2022
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Trial Details
NCT Number NCT05326750
Lead Sponsor Kuopio University Hospital
Conditions
(from sponsor)		 Alzheimer Disease, Frontotemporal Dementia, Dementia With Lewy Bodies
Related terms Alzheimer Disease, Frontotemporal Dementia, Lewy Body Disease
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov